Kandırıcı A, Gürbüz E
Department of Pediatric Surgery and Pediatric Urology, Prof Dr Cemil Taşçıoğlu City Hospital, Istanbul, Turkey.
Hippokratia. 2022 Oct-Dec;26(4):152-156.
Endoscopic retrograde cholangiopancreatography (ERCP) was first applied in 1976 in children for diagnosing and treating pancreaticobiliary diseases based on experience with adult patients. Its application was limited initially but has become widespread in recent years with technical developments. This study evaluated the efficacy, indications, and complications of the ERCP's diagnostic and therapeutic use in pediatric patients.
We evaluated retrospectively the files of 16 pediatric patients aged 5-18 years who underwent ERCP between January 2015 and June 2022 in the Endoscopy Unit of Prof. Dr. Cemil Taşçıoğlu City Hospital. We recorded and analyzed the demographic data, admission complaints, pre-procedure diagnostic tests, ERCP findings, and early and late post-procedure complications. Five of the 16 patients (31 %) who underwent ERCP were male, 11 (69 %) were female, and their mean age was 12.7 ± 5.44. We utilized as a diagnostic tool the Fujifilm ED-580XT duodenoscope with a 13.4 mm outer diameter and a 4.4 mm diameter channel connected to a Fujinon Eluxeo 6000 light source, not specifically designed for children but in use for adult patients. While biochemistry and ultrasonography were conducted for all patients before the procedure, only ten patients (62 %) underwent magnetic resonance cholangiopancreatography. Indications for performing ERCP included suspected biliary pathology (8 patients, 50 %), pancreatitis attack (6 patients, 38 %), bile leakage after cholecystectomy (one patient, 6 %), and mass lesion in the ampulla (one patient, 6 %). Seven patients (44 %) underwent cholecystectomy for cholelithiasis 4-6 weeks after the ERCP (one cholecystectomy was performed in another center). In one of the patients, ERCP was performed for diagnostic-only purposes, while in fifteen patients was performed for diagnostic and therapeutic purposes (partial sphincterotomy and stent placement). While none of the patients had complications in the early post-procedure period, one experienced an acute pancreatitis episode in the late post-procedure period.
With the increase in endoscopists' experience and technological developments in different age groups, ERCP is a safe and effective method for diagnosing and treating pancreaticobiliary diseases in children. HIPPOKRATIA 2022, 26 (4):152-156.
内镜逆行胰胆管造影术(ERCP)于1976年首次应用于儿童,用于诊断和治疗胰胆疾病,其依据是成人患者的经验。该技术最初应用有限,但近年来随着技术发展已广泛应用。本研究评估了ERCP在儿科患者中诊断和治疗应用的疗效、适应症及并发症。
我们回顾性评估了2015年1月至2022年6月在Cemil Taşçıoğlu教授市立医院内镜科接受ERCP的16例5至18岁儿科患者的病历。我们记录并分析了人口统计学数据、入院主诉、术前诊断检查、ERCP检查结果以及术后早期和晚期并发症。16例接受ERCP的患者中,5例(31%)为男性,11例(69%)为女性,平均年龄为12.7±5.44岁。我们使用外径13.4毫米、通道直径4.4毫米的富士胶片ED - 580XT十二指肠镜作为诊断工具,该十二指肠镜连接富士能Eluxeo 6000光源,并非专门为儿童设计,但用于成人患者。所有患者术前均进行了生化检查和超声检查,仅10例(62%)患者接受了磁共振胰胆管造影。进行ERCP的适应症包括疑似胆道病变(8例,50%)、胰腺炎发作(6例,38%)、胆囊切除术后胆漏(1例,6%)以及壶腹部占位性病变(1例,6%)。7例(44%)患者在ERCP术后4至6周因胆结石接受了胆囊切除术(其中1例胆囊切除术在另一家中心进行)。1例患者仅为诊断目的进行了ERCP,15例患者为诊断和治疗目的进行了ERCP(包括部分括约肌切开术和支架置入术)。术后早期无患者出现并发症,但1例患者在术后晚期发生了急性胰腺炎。
随着内镜医师经验的增加以及不同年龄组技术的发展,ERCP是诊断和治疗儿童胰胆疾病的一种安全有效的方法。《希波克拉底》2022年,26(4):152 - 156。